PEDICULICIDE MANUFACTURERS MUST APPLY INDIVIDUALLY FOR EXTENSIONS
This article was originally published in The Tan Sheet
Executive Summary
PEDICULICIDE MANUFACTURERS MUST APPLY INDIVIDUALLY FOR EXTENSIONS to the Dec. 14, 1994 effective date of the OTC final monograph as they phase out old labeling mandated by the Environmental Protection Agency and adopt the new FDA labeling, FDA advised the Nonprescription Drug Manufacturers Association in a June 1 letter. In response to NDMA's request for a one-and-a- half year delay in the effective date, FDA said it would not grant an extension "on a blanket basis for all products."
You may also be interested in...
Supplement GMP Warning Letters Make Modest Debut In 2010
Finalization of a settlement between the Federal Trade Commission and Rexall Sundown regarding unsupported cellulite treatment claims for the firm's Cellasene dietary supplement hinges upon approval of two related class action settlements pending in California and Florida, according to FTC
In Brief
Combe sells most of its OTC brands
People In Brief
Perrigo promotes in pricing, planning